ClinConnect ClinConnect Logo
Search / Trial NCT05442086

Music and ABS as a Potential Anxiety Intervention

Launched by TORONTO METROPOLITAN UNIVERSITY · Jun 28, 2022

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether a combination of calming music and a special type of sound stimulation can help reduce anxiety. Anxiety has become a more common issue, especially among young people. In this trial, researchers will look at how effective this sound treatment is by measuring different physical and psychological responses in participants who have signs of generalized anxiety. Participants who qualify will listen to either the music and sound combination or a control sound for 24 minutes, and researchers will track changes in heart rate, stress hormones, and anxiety levels before and after the session.

To be eligible for the trial, participants must be at least 18 years old, have a score indicating generalized anxiety, and not have any serious heart problems or epilepsy. They should also have normal hearing and not be currently taking anxiety medication. Those who join the study can expect a friendly environment where they will listen to sounds and answer questions about their feelings and musical preferences. Overall, this research aims to understand if this sound-based intervention can effectively help lessen anxiety symptoms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • GAD-2 score of 1 or higher indicating generalized anxiety.
  • Age between 18-30 years
  • Undergraduate student
  • Comfortable speaking and understanding English
  • Self-reported normal hearing
  • Exclusion Criteria:
  • Self-reported history of cardiovascular conditions (e.g., arrhythmia, heart disease)
  • History of seizures or epilepsy

About Toronto Metropolitan University

Toronto Metropolitan University (TMU) is a leading urban institution dedicated to fostering innovative research and academic excellence. As a clinical trial sponsor, TMU leverages its interdisciplinary expertise and cutting-edge facilities to conduct impactful research that addresses pressing health challenges. Through collaboration with healthcare professionals, industry partners, and community stakeholders, TMU aims to translate scientific discoveries into practical solutions, enhancing patient care and advancing public health. Committed to ethical standards and rigorous methodologies, TMU ensures the integrity and reliability of its clinical trials, contributing to the advancement of medical knowledge and practice.

Locations

Toronto, Ontario, Canada

Patients applied

CF

1 patients applied

Trial Officials

Frank Russo, PhD

Principal Investigator

Toronto Metropolitan University (formerly Ryerson University)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials